Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial.
about
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectivesEarly eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder StudyDiuretics: a review and updateAdditional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction.Review article: eplerenone: an underused medication?Aldosterone antagonists in heart failure.Targeting the aldosterone pathway in cardiovascular disease.Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.The future of heart transplantation.Characteristics, Management, and Outcomes of Acute Heart Failure in the Emergency Department: A Multicenter Registry Study with 1-year Follow-up in a Chinese Cohort in Beijing.Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?Mineralocorticoid Receptor Antagonism in Acute Heart Failure.Clinical trials update from the European Society of Cardiology Meeting 2010: SHIFT, PEARL-HF, STAR-heart, and HEBE-III.Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction.Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure.Genomic and rapid effects of aldosterone: what we know and do not know thus far.Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice
P2860
Q26741152-692382F0-2B50-45E9-AA97-8D38B76DDC35Q28239094-CD11EDFD-E5C0-4890-BBE5-3005EFEBAE8BQ28302157-BE0332D9-F2C4-42E3-B29B-0C846622F352Q36792952-0633231E-8E35-41A3-A645-B9058EB02420Q36800757-C8E622BB-59F4-495B-82F9-F00461E2FC95Q37793666-D197ACDE-363B-4CAF-95E4-5E5306FAAD10Q37821172-99D3177E-26EF-4231-9C1E-BD933AF70683Q37951665-99067A4F-56F9-4C84-BC7B-576EA2B075CBQ38005732-12CE5725-6411-4BEB-942E-0E5EB37D4EC5Q38035388-8D99B19B-29E6-47BF-9E1F-014DA59912F2Q38641541-35229BAC-75ED-47BB-8E73-28DF69C999E2Q38731482-981194C2-2006-4C72-9DFA-8158AF3D9513Q40710330-8523EC6C-30BD-45B0-AAB8-A9AACA30585BQ42851021-5B2E6BCD-0F5A-4084-8959-40EFC82DC29BQ45306207-2764E1CB-71A8-4E45-9513-BC6EE2D2B0C0Q48882910-A5717281-7576-49A5-9878-0754F837DC86Q50047461-3F58EB29-21E2-44D6-9934-24D331250710Q51273122-A122687E-2365-46F3-873A-466435EE79DEQ58585770-3846BB91-1636-4BE5-BB04-3CF86CDD56F3
P2860
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Timing of eplerenone initiatio ...... sights from the EPHESUS trial.
@en
Timing of eplerenone initiatio ...... sights from the EPHESUS trial.
@nl
type
label
Timing of eplerenone initiatio ...... sights from the EPHESUS trial.
@en
Timing of eplerenone initiatio ...... sights from the EPHESUS trial.
@nl
prefLabel
Timing of eplerenone initiatio ...... sights from the EPHESUS trial.
@en
Timing of eplerenone initiatio ...... sights from the EPHESUS trial.
@nl
P2093
P2860
P50
P356
P1476
Timing of eplerenone initiatio ...... sights from the EPHESUS trial.
@en
P2093
Chris Adamopoulos
EPHESUS Investigators
John Vincent
Michael Angioi
Renaud Fay
P2860
P304
P356
10.1093/EURJHF/HFP136
P577
2009-11-01T00:00:00Z